Phát triển và xác thực một hệ thống chấm điểm tiên lượng cho bệnh nhân mắc bệnh bạch cầu tủy mãn tính đơn nhân

Bennett, 1982, Proposals for the classification of the myelodysplastic syndromes., Br J Haematol, 51, 189, 10.1111/j.1365-2141.1982.tb08475.x Bennett, 1994, The chronic myeloid leukemias: guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukemia. Proposals by the French-American-British Cooperative leukemia group., Br J Haematol, 87, 746, 10.1111/j.1365-2141.1994.tb06734.x Greenberg, 1997, International scoring system for evaluating prognosis in myelodysplastic syndromes., Blood, 89, 2079, 10.1182/blood.V89.6.2079 Greenberg, 2012, Revised international prognostic scoring system for myelodysplastic syndromes., Blood, 120, 2454, 10.1182/blood-2012-03-420489 Vardiman Orazi, 2008, Chronic myelomonocytic leukaemia., WHO Classification of tumours of haematopoietic and lymphoid tissues, 76 Such, 2011, Cytogenetic risk stratification in chronic myelomonocytic leukemia., Haematologica, 96, 375, 10.3324/haematol.2010.030957 Germing, 2002, New prognostic parameters for chronic myelomonocytic leukemia., Blood, 100, 731, 10.1182/blood-2002-01-0330 Onida, 2002, Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients., Blood, 99, 840, 10.1182/blood.V99.3.840 Worsley, 1988, Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival., Br J Haematol, 68, 17, 10.1111/j.1365-2141.1988.tb04173.x González-Medina, 2002, Two groups of chronic myelomonocytic leukaemia: myelodysplastic and myeloproliferative. Prognostic implications in a series of a single center., Leuk Res, 26, 821, 10.1016/S0145-2126(02)00021-8 Malcovati, 2007, Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes., J Clin Oncol, 25, 3503, 10.1200/JCO.2006.08.5696 Shaffer Gonen, 2005, Concordance probability and discriminatory power in proportional hazards regression., Biometrika, 92, 965, 10.1093/biomet/92.4.965 Malcovati, 2011, Impact of the degree of anemia on the outcome of patients with myelodysplastic syndrome and its integration into the WHO classification-based Prognostic Scoring System (WPSS)., Haematologica, 96, 1433, 10.3324/haematol.2011.044602 Germing, 1998, Problems in the classification of CMML—dysplastic versus proliferative type., Leuk Res, 22, 871, 10.1016/S0145-2126(97)00192-6 Orazi, 2008, The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features., Leukemia, 22, 1308, 10.1038/leu.2008.119 Voglová, 2001, Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia—distinct subgroups or two stages of the same disease?, Leuk Res, 25, 493, 10.1016/S0145-2126(00)00159-4 Nösslinger, 2001, Myelodysplastic syndromes, from French-American-British to World Health Organization: comparison of classifications on 431 unselected patients from a single institution., Blood, 98, 2935, 10.1182/blood.V98.10.2935 Malcovati, 2005, Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making., J Clin Oncol, 23, 7594, 10.1200/JCO.2005.01.7038 Beran, 2007, Prognostic factors and risk assessment in chronic myelomonocytic leukemia: validation study of the M.D. Anderson Prognostic Scoring System., Leuk Lymphoma, 48, 1150, 10.1080/10428190701216386 Kantarjian, 2008, Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System., Cancer, 113, 1351, 10.1002/cncr.23697 Cazzola Meggendorfer, 2012, SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)., Blood, 120, 3080, 10.1182/blood-2012-01-404863 Kohlmann, 2010, Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1., J Clin Oncol, 28, 3858, 10.1200/JCO.2009.27.1361 Jankowska, 2011, Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A., Blood, 118, 3932, 10.1182/blood-2010-10-311019 Yoshida, 2011, Frequent pathway mutations of splicing machinery in myelodysplasia., Nature, 478, 64, 10.1038/nature10496 Smith, 2010, Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value., Blood, 116, 3923, 10.1182/blood-2010-03-274704 Makishima, 2012, Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis., Blood, 119, 3203, 10.1182/blood-2011-12-399774 Malcovati, 2011, Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms., Blood, 118, 6239, 10.1182/blood-2011-09-377275 Kar, 2013, Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia., Haematologica, 98, 107, 10.3324/haematol.2012.064048